Searchable abstracts of presentations at key conferences in endocrinology

ea0099p329 | Pituitary and Neuroendocrinology | ECE2024

Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma

Verena Mann-Markutzyk Laura , Beckhaus Julia , Oezyurt Jale , Friedrich Carsten , Muller Hermann

Background: Adamantinomatous craniopharyngioma (CP) is a rare embryonal malformation originating from remnants of the craniopharyngeal duct and located in the sellar and/or parasellar area. Overall survival rates are high (92%), but frequently quality of life (QoL) is severely impaired in patients with CP involving hypothalamic structures. Tumor- and/or treatment-related hypothalamic lesions result in disturbances of circadian rhythms including increased daytime sleepiness.</p...

ea0088016 | Abstracts | BES2022

Mortality-related risk factors of inpatients with diabetes and COVID-19: a Multicentric Retrospective Study in Belgium

T Servais , F Laurent , C Litvine , Groote E De , V Godart , E Repetto , M Ponchon , P Chasseur , L Crenier , Eeckhoudt S Van , J Yango , P Oriot , M Gavriliu , S Rouhard , B Deketelaer , C Bugli , L Belkhir , D Maiter , M.P Hermans , JC Yombi , Laura Orioli

Purpose: We describe the characteristics and prognosis of inpatients with diabetes and coronavirus disease 2019 (COVID-19) in Belgium.Methods: We conducted a multicentre retrospective study during the first wave of the pandemic, from March 1, 2020 to May 6, 2020. Data on admission of patients with diabetes and hospitalized due to confirmed COVID-19 were collected. COVID-19 diagnosis was based on a positive polymerase chain reaction (PCR) test on nasophar...

ea0090p118 | Endocrine-related Cancer | ECE2023

Survival, obesity and quality of life after childhood-onset craniopharyngioma: The role of age at diagnosis and hypothalamic damage

Beckhaus Julia , Friedrich Carsten , Boekhoff Svenja , Calaminus Gabriele , Bison Brigitte , Eveslage Maria , Timmermann Beate , Flitsch Jorg , Muller Hermann

Background: Adamantinomatous craniopharyngiomas (CP) are rare malformational tumors. The association between age at diagnosis and the outcome, clinical presentation and treatment of pediatric CP patients is not clear. The aim of this cohort study was to determine clinical presentation, outcome and quality of life in CP patients diagnosed at different AaD. Methods: Seven hundred and twenty-two patients diagnosed with CP were recruited 1999-2021 in HIT-End...

ea0041ep739 | Neuroendocrinology | ECE2016

Nuchal Skinfold Thickness: a novel parameter for assessment of body composition in childhood craniopharyngioma

Sterkenburg Anthe S. , Hoffmann Anika , Reichel Julia , Lohle Kristin , Eveslage Maria , Warmuth-Metz Monika , Muller Hermann L.

Context: Hypothalamic obesity, subsequent cardiovascular disease (CVD), and relapses/progression have major impact on prognosis in childhood-onset craniopharyngioma (CP). We analyzed nuchal skinfold thickness (NST) on magnetic resonance imaging (MRI) performed for follow-up monitoring as a novel parameter for body composition (BC) and CVD in CP.Objective: Identify association of NST with body mass index (BMI), waist-to-height ratio (WHtR), caliper-assess...

ea0041ep765 | Neuroendocrinology | ECE2016

History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis

Hoffmann Anika , Boekhoff Svenja , Gebhardt Ursel , Sterkenburg Anthe S , Daubenbuchel Anna M , Eveslage Maria , Muller Hermann L

Objective: Childhood craniopharyngiomas (CP) are often diagnosed after long duration of history (DOH). Tumor size, hypothalamic involvement (HI), and obesity are associated with reduced overall survival (OS) and functional capacity (FC). The effect of DOH and specific symptoms in history on presentation at initial diagnosis and long-term prognosis are unknown.Design: Retrospective analysis of patients’ records and prospective longitudinal follow-up....

ea0032p885 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Xanthogranuloma, Rathke‘s cyst, and Childhood Craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations

Muller Hermann , Gebhardt Ursel , Faldum Andreas , Warmuth-Metz Monika , Pietsch Torsten , Pohl Fabian , Calaminus Gabriele , Sorensen Niels

Background: SUB:Pituitary – Clinical (Generously supported by IPSEN)Craniopharyngioma (CP), Rathke’s cyst (RC) and xanthogranuloma (XG) are closely related rare sellar masses, which share common embryogenic origin. Treatment strategies in children lack consensus, especially in terms of surgical and radiooncological treatment options.Objective: To study clinical manifestations and treatment-related outco-me in RC, XG, and CP patients.</...

ea0020p227 | Bone/Calcium | ECE2009

Experience with cinacalcet in primary hyperparathyroidism: results from the Swiss primary hyperparathyroidism cohort study

Meier Christian , Trombetti Andrea , Henzen Christoph , Rohrer Andreas , Hermann F , Braendle Michael , Christ Emanuel , Rizzoli Rene , Kraenzlin Marius

Objective: Cinacalcet, a calcimimetic that reduces parathyroid hormone (PTH) secretion and serum calcium (S-Ca) levels by increasing the sensitivity of calcium-sensing receptors has been introduced for the treatment of patients with persistent or recurrent primary hyperparathyroidism (PHPT). Within a prospective, non-interventional cohort study we identified patients with newly diagnosed PHPT who have been started on cinacalcet. Patient characteristics, treatment indications a...

ea0014p231 | (1) | ECE2007

Pioglitazone treatment significantly decreases 5-alpha reductase activity and improves metabolic risk factors in PCOS

Glintborg Dorte , Hermann Anne Pernille , Hagen Claus , Veldhuis Johannes , Schmedes Anne , Frystyk Jan , Flyvbjerg Allan , Andersen Marianne

Objective: To investigate the effect of pioglitazone on cortisol metabolism in PCOS.Design: Thirty insulin resistant PCOS patients were randomized to either 16 weeks of pioglitazone (30 mg/day) or placebo treatment. Before and after intervention, patients underwent 24 h 20 min.-integrated blood sampling for measurement of cortisol and 24 h excretion of cortisol, cortisone and steroid metabolites (cortisol, corticosteron, androgen, and 17-hydroxyprogester...

ea0073aep500 | Pituitary and Neuroendocrinology | ECE2021

Cerebral infarction in childhood-onset craniopharyngioma patients – results of kraniopharyngeom 2007

Boekhoff Svenja , Bison Brigitte , Genzel Daniela , Eveslage Maria , Otte Anna , Friedrich Carsten , Jörg Flitsch , Hermann Müller

BackgroundCerebral infarction (CI) is a known vascular complication following treatment of suprasellar tumors. Risk factors for CI, incidence rate, and long-term prognosis are unknown for patients with childhood-onset craniopharyngioma (CP).MethodsMRI of 244 CP patients, recruited between 2007 and 2019 in KRANIOPHARYNGEOM 2007, were reviewed for CI. Risk factors for CI and outcome after CI were analyzed.<...

ea0099p526 | Pituitary and Neuroendocrinology | ECE2024

Epidemiology of hypothalamic obesity in craniopharyngioma and other rare sellar and suprasellar tumors

Witte Julian , Surmann Bastian , Batram Manuel , Weinert Markus , Flume Mathias , Touchot Nicolas , Beckhaus Julia , Friedrich Carsten , Muller Hermann

Background: Hypothalamic obesity (HO) is defined as abnormal weight gain resulting in severe persistent obesity due to physical, tumor- and/or treatment related damage of the hypothalamus. The HO epidemiology is poorly understood. We developed a database algorithm supporting the standardized identification of tumor/treatment-related HO (TTR-HO) patients.Methods: The algorithm is used to estimate incidence rates of TTR-HO patients in the German healthcare...